Machine learning models have seeped into the fabric of our lives, from curating playlists to explaining hard concepts in a few seconds. Beyond convenience, state-of-the-art algorithms are finding ...

Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new paper by investigators from Mass General Brigham ...

Please provide your email address to receive an email when new articles are posted on . A genetic biomarker test was able to predict patients’ semaglutide treatment response after bariatric surgery.

EQT Foundation has invested in UK-based Biographica as part of its seed round, supporting the company’s machine learning platform for faster and more accurate crop gene discovery. Biographica’s ...